314 related articles for article (PubMed ID: 22753648)
1. Defining the Minimally Important Change for the SpondyloArthritis Research Consortium of Canada Spine and Sacroiliac Joint Magnetic Resonance Imaging Indices for Ankylosing Spondylitis.
Maksymowych WP; Lambert RG; Brown LS; Pangan AL
J Rheumatol; 2012 Aug; 39(8):1666-74. PubMed ID: 22753648
[TBL] [Abstract][Full Text] [Related]
2. Adalimumab significantly reduces both spinal and sacroiliac joint inflammation in patients with ankylosing spondylitis: a multicenter, randomized, double-blind, placebo-controlled study.
Lambert RG; Salonen D; Rahman P; Inman RD; Wong RL; Einstein SG; Thomson GT; Beaulieu A; Choquette D; Maksymowych WP
Arthritis Rheum; 2007 Dec; 56(12):4005-14. PubMed ID: 18050198
[TBL] [Abstract][Full Text] [Related]
3. Scoring inflammatory activity of the spine by magnetic resonance imaging in ankylosing spondylitis: a multireader experiment.
Lukas C; Braun J; van der Heijde D; Hermann KG; Rudwaleit M; Østergaard M; Oostveen A; O'Connor P; Maksymowych WP; Lambert RG; Jurik AG; Baraliakos X; Landewé R;
J Rheumatol; 2007 Apr; 34(4):862-70. PubMed ID: 17407241
[TBL] [Abstract][Full Text] [Related]
4. Course of Magnetic Resonance Imaging-Detected Inflammation and Structural Lesions in the Sacroiliac Joints of Patients in the Randomized, Double-Blind, Placebo-Controlled Danish Multicenter Study of Adalimumab in Spondyloarthritis, as Assessed by the Berlin and Spondyloarthritis Research Consortium of Canada Methods.
Pedersen SJ; Poddubnyy D; Sørensen IJ; Loft AG; Hindrup JS; Thamsborg G; Asmussen K; Hendricks O; Nørregaard J; Piil AD; Møller JM; Jurik AG; Balding L; Lambert RG; Sieper J; Østergaard M
Arthritis Rheumatol; 2016 Feb; 68(2):418-29. PubMed ID: 26414004
[TBL] [Abstract][Full Text] [Related]
5. Adalimumab significantly reduces inflammation and serum DKK-1 level but increases fatty deposition in lumbar spine in active ankylosing spondylitis.
Hu Z; Xu M; Li Q; Lin Z; Liao Z; Cao S; Wei Q; Zhang YL; Li T; Jin O; Huang J; Pan Y; Wu Y; Deng X; Gu J
Int J Rheum Dis; 2012 Aug; 15(4):358-65. PubMed ID: 22898215
[TBL] [Abstract][Full Text] [Related]
6. Low-dose infliximab (3 mg/kg) significantly reduces spinal inflammation on magnetic resonance imaging in patients with ankylosing spondylitis: a randomized placebo-controlled study.
Maksymowych WP; Salonen D; Inman RD; Rahman P; Lambert RG;
J Rheumatol; 2010 Aug; 37(8):1728-34. PubMed ID: 20436073
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance imaging of the spine and the sacroiliac joints in ankylosing spondylitis and undifferentiated spondyloarthritis during treatment with etanercept.
Rudwaleit M; Baraliakos X; Listing J; Brandt J; Sieper J; Braun J
Ann Rheum Dis; 2005 Sep; 64(9):1305-10. PubMed ID: 15778243
[TBL] [Abstract][Full Text] [Related]
8. Spondyloarthritis research Consortium of Canada magnetic resonance imaging index for assessment of sacroiliac joint inflammation in ankylosing spondylitis.
Maksymowych WP; Inman RD; Salonen D; Dhillon SS; Williams M; Stone M; Conner-Spady B; Palsat J; Lambert RG
Arthritis Rheum; 2005 Oct; 53(5):703-9. PubMed ID: 16208659
[TBL] [Abstract][Full Text] [Related]
9. Spinal inflammation in the absence of sacroiliac joint inflammation on magnetic resonance imaging in patients with active nonradiographic axial spondyloarthritis.
van der Heijde D; Sieper J; Maksymowych WP; Brown MA; Lambert RG; Rathmann SS; Pangan AL
Arthritis Rheumatol; 2014 Mar; 66(3):667-73. PubMed ID: 24574227
[TBL] [Abstract][Full Text] [Related]
10. Scoring sacroiliac joints by magnetic resonance imaging. A multiple-reader reliability experiment.
Landewé RB; Hermann KG; van der Heijde DM; Baraliakos X; Jurik AG; Lambert RG; Østergaard M; Rudwaleit M; Salonen DC; Braun J
J Rheumatol; 2005 Oct; 32(10):2050-5. PubMed ID: 16206369
[TBL] [Abstract][Full Text] [Related]
11. Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and clinical and MRI measures of disease activity in a 1-year follow-up study of patients with axial spondyloarthritis treated with tumour necrosis factor alpha inhibitors.
Pedersen SJ; Sørensen IJ; Hermann KG; Madsen OR; Tvede N; Hansen MS; Thamsborg G; Andersen LS; Majgaard O; Loft AG; Erlendsson J; Asmussen K; Johansen JS; Jurik AG; Møller J; Hasselquist M; Mikkelsen D; Skjødt T; Hansen A; Ostergaard M
Ann Rheum Dis; 2010 Jun; 69(6):1065-71. PubMed ID: 19740906
[TBL] [Abstract][Full Text] [Related]
12. Is there a preferred method for scoring activity of the spine by magnetic resonance imaging in ankylosing spondylitis?
van der Heijde D; Landewé R; Hermann KG; Rudwaleit M; Østergaard M; Oostveen A; O'Connor P; Maksymowych WP; Lambert RG; Lukas C; Jurik AG; Boers M; Baraliakos X; Braun J;
J Rheumatol; 2007 Apr; 34(4):871-3. PubMed ID: 17407242
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: evaluation of a new scoring system.
Braun J; Baraliakos X; Golder W; Brandt J; Rudwaleit M; Listing J; Bollow M; Sieper J; Van Der Heijde D
Arthritis Rheum; 2003 Apr; 48(4):1126-36. PubMed ID: 12687557
[TBL] [Abstract][Full Text] [Related]
14. MRI in predicting a major clinical response to anti-tumour necrosis factor treatment in ankylosing spondylitis.
Rudwaleit M; Schwarzlose S; Hilgert ES; Listing J; Braun J; Sieper J
Ann Rheum Dis; 2008 Sep; 67(9):1276-81. PubMed ID: 18006539
[TBL] [Abstract][Full Text] [Related]
15. Validation of whole-body against conventional magnetic resonance imaging for scoring acute inflammatory lesions in the sacroiliac joints of patients with spondylarthritis.
Weber U; Maksymowych WP; Jurik AG; Pfirrmann CW; Rufibach K; Kissling RO; Khan MA; Lambert RG; Hodler J
Arthritis Rheum; 2009 Jul; 61(7):893-9. PubMed ID: 19565546
[TBL] [Abstract][Full Text] [Related]
16. Structural progression rate decreases over time on serial radiography and magnetic resonance imaging of sacroiliac joints and spine in a five-year follow-up study of patients with ankylosing spondylitis treated with tumour necrosis factor inhibitor.
Pedersen SJ; Weber U; Said-Nahal R; Sørensen IJ; Loft AG; Kollerup G; Juul L; Frandsen PB; Thamsborg G; Madsen OR; Møller J; Balding L; Jurik AG; Østergaard M
Scand J Rheumatol; 2019 May; 48(3):185-197. PubMed ID: 30422733
[TBL] [Abstract][Full Text] [Related]
17. Tofacitinib is associated with attainment of the minimally important reduction in axial magnetic resonance imaging inflammation in ankylosing spondylitis patients.
Maksymowych WP; van der Heijde D; Baraliakos X; Deodhar A; Sherlock SP; Li D; Fleishaker D; Hendrikx T; Kanik KS
Rheumatology (Oxford); 2018 Aug; 57(8):1390-1399. PubMed ID: 29718421
[TBL] [Abstract][Full Text] [Related]
18. Adalimumab reduces spinal symptoms in active ankylosing spondylitis: clinical and magnetic resonance imaging results of a fifty-two-week open-label trial.
Haibel H; Rudwaleit M; Brandt HC; Grozdanovic Z; Listing J; Kupper H; Braun J; Sieper J
Arthritis Rheum; 2006 Feb; 54(2):678-81. PubMed ID: 16447247
[No Abstract] [Full Text] [Related]
19. MRI inflammation and its relation with measures of clinical disease activity and different treatment responses in patients with ankylosing spondylitis treated with a tumour necrosis factor inhibitor.
Machado P; Landewé RB; Braun J; Baraliakos X; Hermann KG; Hsu B; Baker D; van der Heijde D
Ann Rheum Dis; 2012 Dec; 71(12):2002-5. PubMed ID: 22915615
[TBL] [Abstract][Full Text] [Related]
20. Metric Properties of the SPARCC Score of the Sacroiliac Joints - Data from Baseline, 3-month, and 12-month Followup in the SPACE Cohort.
van den Berg R; de Hooge M; Bakker PA; van Gaalen F; Navarro-Compán V; Fagerli KM; Landewé R; van Oosterhout M; Ramonda R; Reijnierse M; van der Heijde D
J Rheumatol; 2015 Jul; 42(7):1186-93. PubMed ID: 25934824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
